Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 15, 2023

SELL
$8.83 - $17.61 $33.2 Million - $66.3 Million
-3,764,527 Reduced 94.04%
238,691 $2.18 Million
Q4 2022

Feb 14, 2023

BUY
$10.88 - $20.05 $9.95 Million - $18.3 Million
914,713 Added 29.62%
4,003,218 $45.7 Million
Q3 2022

Nov 14, 2022

BUY
$16.06 - $26.39 $3.23 Million - $5.31 Million
201,396 Added 6.98%
3,088,505 $52.6 Million
Q2 2022

Aug 15, 2022

BUY
$20.49 - $39.72 $10.9 Million - $21.1 Million
530,911 Added 22.53%
2,887,109 $62 Million
Q1 2022

May 16, 2022

BUY
$28.19 - $46.6 $17.4 Million - $28.8 Million
617,264 Added 35.5%
2,356,198 $87.2 Million
Q4 2021

Feb 14, 2022

BUY
$41.2 - $73.6 $36.7 Million - $65.6 Million
891,581 Added 105.22%
1,738,934 $79.1 Million
Q3 2021

Nov 15, 2021

BUY
$59.15 - $91.99 $12.4 Million - $19.3 Million
209,791 Added 32.91%
847,353 $53.7 Million
Q2 2021

Aug 16, 2021

BUY
$63.02 - $95.11 $20.7 Million - $31.2 Million
327,699 Added 105.76%
637,562 $58.4 Million
Q1 2021

May 17, 2021

SELL
$57.62 - $95.6 $9.94 Million - $16.5 Million
-172,502 Reduced 35.76%
309,863 $21.1 Million
Q4 2020

Feb 16, 2021

SELL
$41.43 - $77.09 $11.1 Million - $20.6 Million
-267,147 Reduced 35.64%
482,365 $34.9 Million
Q3 2020

Nov 16, 2020

SELL
$30.88 - $37.94 $2.51 Million - $3.09 Million
-81,438 Reduced 9.8%
749,512 $28.4 Million
Q2 2020

Aug 14, 2020

SELL
$18.95 - $35.43 $3.69 Million - $6.9 Million
-194,878 Reduced 19.0%
830,950 $29.4 Million
Q1 2020

May 15, 2020

BUY
$13.94 - $28.25 $4.5 Million - $9.11 Million
322,513 Added 45.86%
1,025,828 $22.4 Million
Q4 2019

Feb 14, 2020

BUY
$19.24 - $28.41 $2.05 Million - $3.03 Million
106,796 Added 17.9%
703,315 $15.2 Million
Q3 2019

Nov 14, 2019

BUY
$20.03 - $40.08 $821,951 - $1.64 Million
41,036 Added 7.39%
596,519 $13.5 Million
Q2 2019

Aug 14, 2019

SELL
$25.78 - $39.77 $4.39 Million - $6.77 Million
-170,298 Reduced 23.46%
555,483 $20 Million
Q1 2019

May 15, 2019

SELL
$22.09 - $39.21 $2.58 Million - $4.58 Million
-116,903 Reduced 13.87%
725,781 $22.9 Million
Q4 2018

Feb 14, 2019

SELL
$19.89 - $30.02 $1.07 Million - $1.61 Million
-53,790 Reduced 6.0%
842,684 $21.2 Million
Q3 2018

Nov 14, 2018

SELL
$12.1 - $28.85 $5.35 Million - $12.8 Million
-442,094 Reduced 33.03%
896,474 $25.9 Million
Q2 2018

Aug 14, 2018

BUY
$7.93 - $15.79 $10.6 Million - $21.1 Million
1,338,568 New
1,338,568 $16.4 Million

Others Institutions Holding CDNA

About CareDx, Inc.


  • Ticker CDNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 53,458,100
  • Market Cap $1.26B
  • Description
  • CareDx, Inc. discovers, develops, and commercializes diagnostic solutions for transplant patients and caregivers worldwide. It provides AlloSure Kidney, a donor-derived cell-free DNA (dd-cfDNA) solution for kidney transplant patients; AlloMap Heart, a gene expression solution for heart transplant patients; AlloSure Heart, a dd-cfDNA solution for...
More about CDNA
Track This Portfolio

Track Arrow Mark Colorado Holdings LLC Portfolio

Follow Arrow Mark Colorado Holdings LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Arrow Mark Colorado Holdings LLC, based on Form 13F filings with the SEC.

News

Stay updated on Arrow Mark Colorado Holdings LLC with notifications on news.